Effects of proinsulin C-peptide on oxygen transport, uptake and utilization in insulinopenic diabetic subjects - A review

Advances in Experimental Medicine and Biology

Volumn 645, Issue , 2009, Pages 193-198

  Nordquist, Lina ^a   Stridh, Sara ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ADENOSINE TRIPHOSPHATE; C PEPTIDE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; INSULIN; NEUROPROTECTIVE AGENT; OXYGEN;

CONFERENCE PAPER; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE DEFORMABILITY; EYE PROTECTION; HEART PROTECTION; HUMAN; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MICROCIRCULATION; NEUROPROTECTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXYGEN CONSUMPTION; OXYGEN TRANSPORT; PRIORITY JOURNAL; RENAL PROTECTION; VASODILATATION; ANIMAL; METABOLISM; REVIEW;

ANIMALS; C-PEPTIDE; DIABETES MELLITUS; HUMANS; INSULIN; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; OXYGEN;

EID: 61849114600     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-85998-9_30     Document Type: Conference Paper

References (42)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group, N Engl J Med 329(14), 977-86(1993).
2. J. Ditzel, and E. Standl, The problem of tissue oxygenation in diabetes mellitus, Acta Med Scand Suppl 578 59-68 (1975).
3. T. Jensen, E. A. Richter, B. Feldt-Rasmussen, H. Kelbaek, and T. Deckert, Impaired aerobic work capacity in insulin dependent diabetics with increased urinary albumin excretion, Br Med J (Clin Res Ed) 296(6633), 1352-4(1988).
4. J. C. Lee, and S. E. Downing, Coronary dynamics and myocardial metabolism in the diabetic newborn lamb, Am J Physiol 237(2), H118-24(1979). (Pubitemid 10229596)
5. T. D. Bell, G. F. DiBona, Y. Wang, and M. W. Brands, Mechanisms for renal blood flow control early in diabetes as revealed by chronic flow measurement and transfer function analysis, J Am Soc Nephrol 17(8), 2184-92(2006). (Pubitemid 44141908)
6. B. L. Johansson, B. Linde, and J. Wahren, Effects of C-peptide on blood flow, capillary diffusion capacity and glucose utilization in the exercising forearm of type 1(insulin-dependent) diabetic patients, Diabetologia 35(12), 1151-8(1992).
7. B. L. Johansson, J. Wahren, and J. Pernow, C-peptide increases forearm blood flow in patients with type 1 diabetes via a nitric oxide-dependent mechanism, Am J Physiol Endocrinol Metab 285(4), E864-70 (2003). (Pubitemid 37179996)
8. T. Forst, T. Kunt, T. Pohlmann, K. Goitom, M. Engelbach, J. Beyer, and A. Pfutzner, Biological activity of C-peptide on the skin microcirculation in patients with insulin-dependent diabetes mellitus, J Clin Invest 101(10), 2036-41(1998). (Pubitemid 28244087)
9. A. Hansen, B. L. Johansson, J. Wahren, and H. von Bibra, C-peptide exerts beneficial effects on myocardial blood flow and function in patients with type 1 diabetes, Diabetes 51(10), 3077-82(2002).
10. R. Sari, and M. K. Balci, Relationship between C peptide and chronic complications in type-2 diabetes mellitus, J Natl Med Assoc 97(8), 1113-8(2005). (Pubitemid 41098538)
11. T. Traupe, P. C. Nett, B. Frank, L. Tornillo, R. Hofmann-Lehmann, L. M. Terracciano, and M. Barton, Impaired vascular function in normoglycemic mice prone to autoimmune diabetes: role of nitric oxide, Eur J Pharmacol 557(2-3), 161-7(2007). (Pubitemid 46186285)
12. T. Thum, D. Fraccarollo, M. Schultheiss, S. Froese, P. Galuppo, J. D. Widder, D. Tsikas, G. Ertl, and J. Bauersachs, Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes, Diabetes 56(3), 666-74(2007). (Pubitemid 46348461)
13. H. Li, L. Xu, J. C. Dunbar, C. B. Dhabuwala, and A. A. Sima, Effects of C-peptide on expression of eNOS and iNOS in human cavernosal smooth muscle cells, Urology 64(3), 622-7(2004). (Pubitemid 39200786)
14. T. Wallerath, T. Kunt, T. Forst, E. I. Closs, R. Lehmann, T. Flohr, M. Gabriel, D. Schafer, A. Gopfert, A. Pfutzner, J. Beyer, and U. Forstermann, Stimulation of endothelial nitric oxide synthase by proinsulin C-peptide, Nitric Oxide 9(2), 95-102(2003). (Pubitemid 37386378)
15. L. H. Young, Y. Ikeda, R. Scalia, and A. M. Lefer, C-peptide exerts cardioprotective effects in myocardial ischemia-reperfusion, Am J Physiol Heart Circ Physiol 279(4), H1453-9 (2000).
16. R. S. Sprague, M. L. Ellsworth, A. H. Stephenson, and A. J. Lonigro, ATP: the red blood cell link to NO and local control of the pulmonary circulation, Am J Physiol 271(6 Pt 2), H2717-22 (1996).
17. R. S. Sprague, J. J. Olearczyk, D. M. Spence, A. H. Stephenson, R. W. Sprung, and A. J. Lonigro, Extracellular ATP signaling in the rabbit lung: erythrocytes as determinants of vascular resistance, Am J Physiol Heart Circ Physiol 285(2), H693-700 (2003). (Pubitemid 36885902)
18. D. E. McMillan, N. G. Utterback, and J. La Puma, Reduced erythrocyte deformability in diabetes, Diabetes 27(9), 895-901(1978). (Pubitemid 9023045)
19. D. D. De La Tour, D. Raccah, M. F. Jannot, T. Coste, C. Rougerie, and P. Vague, Erythrocyte Na/K ATPase activity and diabetes: relationship with C-peptide level, Diabetologia 41(9), 1080-4(1998). (Pubitemid 28394414)
20. T. Kunt, S. Schneider, A. Pfutzner, K. Goitum, M. Engelbach, B. Schauf, J. Beyer, and T. Forst, The effect of human proinsulin C-peptide on erythrocyte deformability in patients with Type I diabetes mellitus, Diabetologia 42(4), 465-71(1999). (Pubitemid 29148406)
21. D. Raccah, C. Fabreguetts, J. P. Azulay, and P. Vague, Erythrocyte Na (+)-K (+)-ATPase activity, metabolic control, and neuropathy in IDDM patients, Diabetes Care 19(6), 564-8(1996). (Pubitemid 26181101)
22. T. Forst, D. D. De La Tour, T. Kunt, A. Pfutzner, K. Goitom, T. Pohlmann, S. Schneider, B. L. Johansson, J. Wahren, M. Lobig, M. Engelbach, J. Beyer, and P. Vague, Effects of proinsulin C-peptide on nitric oxide, microvascular blood flow and erythrocyte Na+, K+-ATPase activity in diabetes mellitus type I, Clin Sci (Lond) 98(3), 283-90(2000). (Pubitemid 30145234)
23. A. A. Sima, W. Zhang, and G. Grunberger, Type 1 diabetic neuropathy and C-peptide, Exp Diabesity Res 5(1), 65-77(2004). (Pubitemid 38477266)
24. C. B. Kremser, N. S. Levitt, K. M. Borow, J. B. Jaspan, C. Lindbloom, K. S. Polonsky, and A. R. Leff, Oxygen uptake kinetics during exercise in diabetic neuropathy, J Appl Physiol 65(6), 2665-71(1988). (Pubitemid 19026437)
25. D. A. Greene, and S. A. Lattimer, Impaired energy utilization and Na-K-ATPase in diabetic peripheral nerve, Am J Physiol 246(4 Pt 1), E311-8(1984). (Pubitemid 14144230)
26. W. Zhang, M. Yorek, C. R. Pierson, Y. Murakawa, A. Breidenbach, and A. A. Sima, Human C-peptide dose dependently prevents early neuropathy in the BB/Wor-rat, Int J Exp Diabetes Res 2(3), 187-93(2001).
27. Z. G. Li, and A. A. Sima, C-peptide and central nervous system complications in diabetes, Exp Diabesity Res 5(1), 79-90(2004). (Pubitemid 38477267)
28. F. Palm, D. G. Buerk, P. O. Carlsson, P. Hansell, and P. Liss, Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation, Diabetes 54(11), 3282-7(2005). (Pubitemid 43334386)
29. J. Shafqat, L. Juntti-Berggren, Z. Zhong, K. Ekberg, M. Kohler, P. O. Berggren, J. Johansson, J. Wahren, and H. Jornvall, Proinsulin C-peptide and its analogues induce intracellular Ca2+ increases in human renal tubular cells, Cell Mol Life Sci 59(7), 1185-9(2002).
30. N. M. Al-Rasheed, F. Meakin, E. L. Royal, A. J. Lewington, J. Brown, G. B. Willars, and N. J. Brunskill, Potent activation of multiple signalling pathways by C-peptide in opossum kidney proximal tubular cells, Diabetologia 47(6), 987-97(2004). (Pubitemid 38918157)
31. B. L. Johansson, K. Borg, E. Fernqvist-Forbes, A. Kernell, T. Odergren, and J. Wahren, Beneficial effects of C-peptide on incipient nephropathy and neuropathy in patients with Type 1 diabetes mellitus, Diabet Med 17(3), 181-9(2000). (Pubitemid 30212289)
32. T. Forst, T. Kunt, A. Pfutzner, J. Beyer, and J. Wahren, New aspects on biological activity of C-peptide in IDDM patients, Exp Clin Endocrinol Diabetes 106(4), 270-6(1998). (Pubitemid 28457006)
33. M. Nangaku, Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure, J Am Soc Nephrol 17(1), 17-25(2006).
34. N. A. Lassen, O. Munck, and J. H. Thaysen, Oxygen consumption and sodium reabsorption in the kidney, Acta Physiol Scand 51 (371-84) (1961).
35. A. Korner, A. C. Eklof, G. Celsi, and A. Aperia, Increased renal metabolism in diabetes. Mechanism and functional implications, Diabetes 43(5), 629-33(1994). (Pubitemid 24138773)
36. L. Nordquist, Fasching, A., Palm, F. C-peptide-Induced Reduction in Oxygen Consumption in Isolated Proximal Tubular Cells from Diabetic Rats is Inhibited by Pretreatment with Ouabain, but not L-NAME. In: International Society on Oxygen Transport to Tissue; 2007; Uppsala, Sweden; 2007.
37. E. C. Carlson, and N. J. Bjork, SEM and TEM analyses of isolated human retinal microvessel basement membranes in diabetic retinopathy, Anat Rec 226(3), 295-306(1990). (Pubitemid 20103336)
38. E. Beltramo, S. Buttiglieri, F. Pomero, A. Allione, F. D'Alu, E. Ponte, and M. Porta, A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose, Diabetologia 46(3), 409-15(2003). (Pubitemid 36547597)
39. S. Chakrabarti, Z. A. Khan, M. Cukiernik, W. Zhang, and A. A. Sima, C-peptide and retinal microangiopathy in diabetes, Exp Diabesity Res 5(1), 91-6(2004). (Pubitemid 38477268)
40. Z. A. Khan, M. Cukiernik, J. R. Gonder, and S. Chakrabarti, Oncofetal fibronectin in diabetic retinopathy, Invest Ophthalmol Vis Sci 45(1), 287-95(2004). (Pubitemid 38055700)
41. P. Castellani, G. Viale, A. Dorcaratto, G. Nicolo, J. Kaczmarek, G. Querze, and L. Zardi, The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis, Int J Cancer 59(5), 612-8(1994). (Pubitemid 24358583)
42. T. V. Karelina, and A. Z. Eisen, Interstitial collagenase and the ED-B oncofetal domain of fibronectin are markers of angiogenesis in human skin tumors, Cancer Detect Prev 22(5), 438-44(1998). (Pubitemid 28395561)